← ZIMMER BIOMET HOLDINGS, INC. ZBH
Market Price
$100.62
Market Cap
$19.26B
P/E Ratio
28.34
Revenue (FY 2025)
↑7.2% YoY
$8.23B
3-Yr CAGR: 5.9%
Net Income
↓-22.0% YoY
$705.10M
Net Margin: 8.6%
Free Cash Flow
↑13.7% YoY
$1.47B
FCF Yield: 7.64%
EPS (Diluted)
↓-19.9% YoY
$3.55
Basic: $3.56
Return on Equity
Efficiency
5.6%
ROA: 131.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ZBH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $7,683.9M | — | $5,302.1M | $305.9M | — | $1.47 | — | $1,632.2M | $1,447.5M | — |
| FY 2017 | $7,824.1M | +1.8% | $5,691.2M | $1,813.8M | +492.9% | $8.64 | +489.4% | $1,582.3M | $1,426.3M | -1.5% |
| FY 2018 | $7,932.9M | +1.4% | $5,661.0M | $-379.2M | -120.9% | $-1.81 | -120.9% | $1,747.4M | $1,584.7M | +11.1% |
| FY 2019 | $7,982.2M | +0.6% | $5,729.6M | $1,131.6M | +398.4% | $5.31 | +394.1% | $1,585.8M | $1,378.7M | -13.0% |
| FY 2020 | $7,024.5M | -12.0% | $4,896.2M | $-138.9M | -112.3% | $-0.65 | -112.2% | $1,204.5M | $1,087.0M | -21.2% |
| FY 2021 | $7,836.2M | +11.6% | $5,495.2M | $401.6M | +389.1% | $1.85 | +385.1% | $1,499.2M | $1,327.2M | +22.1% |
| FY 2022 | $6,939.9M | -11.4% | $4,920.4M | $231.4M | -42.4% | $1.10 | -40.7% | $-71.5M | $-259.4M | -119.5% |
| FY 2023 | $7,394.2M | +6.5% | $5,310.4M | $1,024.0M | +342.5% | $4.88 | +343.6% | — | $-291.1M | -12.2% |
| FY 2024 | $7,678.6M | +3.8% | $5,487.4M | $903.8M | -11.7% | $4.43 | -9.2% | $1,499.4M | $1,295.6M | +545.1% |
| FY 2025 | $8,231.5M | +7.2% | $5,737.8M | $705.1M | -22.0% | $3.55 | -19.9% | $1,697.1M | $1,472.6M | +13.7% |
Valuation
Market Price
$100.62
Market Cap
$19.26B
Enterprise Value
$26.19B
P/E Ratio
28.34
P/B Ratio
1.53
FCF Yield
7.64%
Dividend Yield
0.95%
Shares Outstanding
Profitability & Margins
Gross Margin
69.71%
Operating Margin
13.34%
Net Margin
8.57%
Return on Equity (ROE)
5.55%
Return on Assets (ROA)
131.23%
Asset Turnover
15.32x
Revenue 3-Yr CAGR
5.85%
Financial Health & Liquidity
Current Ratio
0.64
Cash Ratio
0.71
Debt / Equity
0.592
Debt / Assets
13.994
Cash & Equivalents
$591.90M
Total Debt
$7.52B
Book Value / Share
$65.63
Cash Flow Efficiency
Operating Cash Flow
$1.70B
Capital Expenditures (CapEx)
$224.50M
Free Cash Flow
$1.47B
OCF / Revenue
20.62%
FCF / Revenue
17.89%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$3.55
EPS (Basic)
$3.56
Dividends / Share
$0.96
Book Value / Share
$65.63
EPS YoY Growth
-19.86%
Balance Sheet (FY 2025)
Total Assets
$537.30M
Total Liabilities
$834.50M
Stockholders' Equity
$12.70B
Current Assets
$537.30M
Current Liabilities
$834.50M